China Natural Resources, Inc. (CHNR) vs Arcadia Biosciences, Inc. (RKDA)

A side-by-side comparison of China Natural Resources, Inc. and Arcadia Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CHNR vs RKDA

growth of $100 · dividends reinvested · last 10y
CHNR -94.3% (-25.0%/yr)RKDA -100.0% (-57.7%/yr)CHNR compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$6$0
CHNR RKDA

CHNR vs RKDA: by the numbers

  • •CHNR is the larger company ($5M vs $445782 market cap).
  • •Both run net losses; CHNR's is the smaller (0.00% vs -234.53% net margin).

Metrics side by side

Valuation

MetricCHNRRKDA
P/S ratioN/A0.09
P/B ratio0.420.70

Profitability

MetricCHNRRKDA
Gross margin0.00%34.58%
Operating margin0.00%-205.74%
Net margin0.00%-234.53%
ROE-1.39%-1758.45%
ROIC-1.38%-95.57%

Growth (annualized)

MetricCHNRRKDA
Revenue CAGR (5Y)N/A-13.28%
Total return CAGR (5Y)-39.47%-67.74%

Frequently asked

How have CHNR and RKDA total returns compared?
Over the past 10 years, CHNR delivered -25.01% and RKDA delivered -57.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.